1 matches for your search in the start-up spotlight
rss
matching the following criteria
Sort by:
MIP Discovery Limited
MIP Discovery designs and develops non-biological affinity reagents to accelerate the development and production of cell and gene therapies. Taking the industry beyond the limitations of biological reagents, these synthetic antibody alternatives enable greater insight and control over viral ...
